Picture of Moberg Pharma AB (publ) logo

MOB Moberg Pharma AB (publ) Income Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual income statement for Moberg Pharma AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
June 30th
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:6 M18 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue15.650.500.2070
Cost of Revenue
Gross Profit15.650.500
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses19.834.519.720.427.5
Operating Profit-4.2216-19.7-20.2-27.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-5.0713.4-20-19.5-25.4
Provision for Income Taxes
Net Income After Taxes-4.7310.2-16.2-15.7-21.1
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income5598.87.49-15.7-21.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income5598.87.49-15.7-21.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.483.36-2.41-1.38-1.33
Dividends per Share